Precision. Medicine. Advisors.
Providing regulatory intelligence to industry pioneers.
Our Services
Strategy Development
FDA Submissions
IVD TPLC Support
Expert Advisory Opinion
Goldbug’s unique approach to solving the most vexing regulatory challenges has consistently produced unprecedented outcomes for our clients. I am proud of the value we bring to the diagnostic community and look forward to further enabling their success in advancing precision medicine.
Recent News
Guardant Health Releases Results from ECLIPSE
https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx Last week, Guardant Health released the results of...
Johns Hopkins Research Team Publishes Findings from Novel AI Blood Test for Liver Cancer Detection
https://www.hopkinsmedicine.org/news/newsroom/news-releases/novel-ai-blood-test-detects-liver-cancer A research team led by Johns Hopkins Kimmel Cancer Center developed a circulating cell-free DNA (cfDNA) "fragmentome" and machine learning approach to boost...
FDA Explores Alternatives to CDx with New Pilot Program
https://www.fiercebiotech.com/medtech/fda-looks-bypass-cancer-drugs-companion-diagnostics-new-pilot-program-pazdur FDA had begun exploring ways around the one-drug-one-test limitations of companion diagnostics by looking further into the ‘minimal performance criteria’...